Antibody therapy of malignancy.
Dyer
M J
MJ
Department of Academic Haematology and Cytogenetics, Royal Marsden Hospital, Sutton, Surrey, U.K.
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D006801:Humans; D007128:Immunoglobulin Fragments; D007167:Immunotherapy / Q000379:methods; D000922:Immunotoxins / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000628:therapy; D051379:Mice; D009369:Neoplasms / Q000628:therapy*; D051381:Rats
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D007128:Immunoglobulin Fragments; D000922:Immunotoxins